Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-03

Clinical Trial Update: Study of LX4211 in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 study of LX4211 in subjects with Type 2 Diabetes Mellitus has completed, with results posted in March 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LX4211 (LX4211)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2011-03-03